| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Inovio Pharmaceuticals, Inc. (INO) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. INO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 86.6K | $113.9K | - | |
| CEO | 84.9K | $111.6K | - | |
| CFO | 26.1K | $34.3K | - | |
| Other | 18.1K | $23.8K | - | |
| Dir | 12.2K | $16.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | Zoth Lota S.59 | Director | Sell | 5,700 | $0.56 | $3,192.00 | -9.8% | -20.0% | +46.2% | |
| Mar 13, 2023 | Weiner David B.82 | Director | Sale+OE | 5,833 | $1.15 | $6,707.95 | -0.6% | -58.7% | -20.1% | |
| Feb 27, 2023 | Weiner David B.82 | Director | Sale+OE | 11,668 | $1.28 | $14,935.04 | -1.3% | -52.4% | -39.4% | |
| Aug 11, 2022 | Weiner David B.82 | Director | Sale+OE | 11,875 | $2.66 | $31,587.50 | -1.3% | -11.4% | -81.6% | |
| Jul 20, 2022 | Benito Simon X80 | Director | Sale+OE | 2,000 | $2.25 | $4,500.00 | -2.6% | -19.3% | -75.8% | |
| May 16, 2022 | Weiner David B.82 | Director | Sale+OE | 9,000 | $1.95 | $17,550.00 | -1.0% | +47.6% | -63.0% | |
| May 16, 2022 | Zoth Lota S.59 | Director | Sale+OE | 3,600 | $1.98 | $7,128.00 | -8.4% | +47.6% | -63.0% | |
| Mar 16, 2022 | Benito Simon X80 | Director | Sale+OE | 2,000 | $3.16 | $6,320.00 | -3.4% | -56.4% | -65.8% | |
| Mar 14, 2022 | Weiner David B.82 | Director | Sale+OE | 4,083 | $3.20 | $13,065.60 | -0.5% | -51.7% | -61.3% | |
| Mar 9, 2022 | Weiner David B.82 | Director | Sale+OE | 4,083 | $3.33 | $13,596.39 | -0.5% | -47.2% | -66.5% |